In this report, our team research the global Opioid Induced Constipation (OIC) Drugs market by type, application, region and manufacturer 2013-2018 and forcast 2019-2024. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Opioid Induced Constipation (OIC) Drugs in these regions, from 2012 to 2023 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Opioid Induced Constipation (OIC) Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Opioid Induced Constipation (OIC) Drugs for each application, including
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Opioid Induced Constipation (OIC) Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Opioid Induced Constipation (OIC) Drugs Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Product Type Market
2.1 World Product Type Market Performance and Trend
2.1.1 World Market Performance
2.1.2 Different Type of Market Performance
2.2 North America Product Type Market Performance and Trend
2.2.1 North America Market Performance
2.2.2 Different Type of Market Performance
2.3 Europe Product Type Market Performance and Trend
2.3.1 Europe Market Performance
2.3.2 Different Type of Market Performance
2.4 Asia-Pacific Product Type Market Performance and Trend
2.4.1 Asia-Pacific Market Performance
2.4.2 Different Type of Market Performance
2.5 South America Product Type Market Performance and Trend
2.5.1 South America Market Performance
2.5.2 Different Type of Market Performance
2.6 Middle East and Africa Product Type Market Performance and Trend
2.6.1 Middle East and Africa Market Performance
2.6.2 Different Type of Market Performance
3 Product Application Market
3.1 World Product Application Market Performance and Trend
3.1.1 World Market Performance
3.1.2 Different Applications of Market Trend
3.2 North America Product Application Market Performance and Trend
3.2.1 North America Market Performance
3.2.2 Different Applications of Market Trend
3.3 Europe Product Application Market Performance and Trend
3.3.1 Europe Market Performance
3.3.2 Different Applications of Market Trend
3.4 Asia-Pacific Product Application Market Performance and Trend
3.4.1 Asia-Pacific Market Performance
3.4.2 Different Applications of Market Trend
3.5 South America Product Application Market Performance and Trend
3.5.1 South America Market Performance
3.5.2 Different Applications of Market Trend
3.6 Middle East and Africa Product Application Market Performance and Trend
3.6.1 Middle East and Africa Market Performance
3.6.2 Different Applications of Market Trend
4 Manufacturers Profiles/Analysis
4.1 Ironwood Pharmaceuticals Inc
4.1.1 Ironwood Pharmaceuticals Inc Profiles
4.1.2 Ironwood Pharmaceuticals Inc Product Information
4.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Performance
4.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.2 Daiichi Sankyo Co Ltd
4.2.1 Daiichi Sankyo Co Ltd Profiles
4.2.2 Daiichi Sankyo Co Ltd Product Information
4.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Business Performance
4.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.3 Pfizer
4.3.1 Pfizer Profiles
4.3.2 Pfizer Product Information
4.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Business Performance
4.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.4 Progenics Pharmaceuticals Inc
4.4.1 Progenics Pharmaceuticals Inc Profiles
4.4.2 Progenics Pharmaceuticals Inc Product Information
4.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Performance
4.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.5 Shionogi & Co., Ltd
4.5.1 Shionogi & Co., Ltd Profiles
4.5.2 Shionogi & Co., Ltd Product Information
4.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Business Performance
4.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.6 Allergan Plc
4.6.1 Allergan Plc Profiles
4.6.2 Allergan Plc Product Information
4.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Business Performance
4.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.7 Nektar Therapeutics
4.7.1 Nektar Therapeutics Profiles
4.7.2 Nektar Therapeutics Product Information
4.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Business Performance
4.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.8 Purdue Pharma
4.8.1 Purdue Pharma Profiles
4.8.2 Purdue Pharma Product Information
4.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Business Performance
4.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.9 S.L.A. Pharma AG
4.9.1 S.L.A. Pharma AG Profiles
4.9.2 S.L.A. Pharma AG Product Information
4.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Business Performance
4.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.10 Mundipharma International Limited
4.10.1 Mundipharma International Limited Profiles
4.10.2 Mundipharma International Limited Product Information
4.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Business Performance
4.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.11 Ono Pharmaceutical Co., Ltd
4.12 Takeda Pharmaceutical Company Limited
4.13 Pfizer
4.14 Progenics Pharmaceuticals Inc
4.15 Shionogi & Co., Ltd
6.1.1 Published Date: Jun. 2019 Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2019
5 Market Performance for Manufacturers
5.1 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Market Share by Manufacturers 2013-2018
5.2 Global Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018
5.3 Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
5.4 Global Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 North America Market Performance for Manufacturers
6.1.1 North America Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.1.2 North America Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.1.3 North America Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.1.4 North America Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.1.5 Market Concentration
6.2 Europe Market Performance for Manufacturers
6.2.1 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.2.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.2.3 Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.2.4 Europe Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.2.5 Market Concentration
6.3 Asia-Pacific Market Performance for Manufacturers
6.3.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.3.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.3.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.3.4 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.3.5 Market Concentration
6.4 South America Market Performance for Manufacturers
6.4.1 South America Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.4.2 South America Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.4.3 South America Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.4.4 South America Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.4.5 Market Concentration
6.5 Middle East and Africa Market Performance for Manufacturers
6.5.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.5.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.5.3 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.5.4 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.5.5 Market Concentration
7 World Market Performance Point
7.1 World Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share by Regions and Countries 2013-2018
7.1.1 World Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share by Regions 2013-2018
7.1.2 Regional Sales (K Units) and Share by Countries 2013-2018
7.1.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share by Countries 2013-2018
7.1.2.2 North America Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share by Countries 2013-2018
7.1.2.3 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share by Countries 2013-2018
7.1.2.4 South America Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share by Countries 2013-2018
7.1.2.5 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share by Countries 2013-2018
7.2 World Revenue (M USD) and Share by Regions and Countries 2013-2018
7.2.1 World Revenue (M USD) and Share by Regions 2013-2018
7.2.2 Regional Revenue (M USD) and Share by Countries 2013-2018
7.2.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share by Countries 2013-2018
7.2.2.2 North America Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share by Countries 2013-2018
7.2.2.3 Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share by Countries 2013-2018
7.2.2.4 South America Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share by Countries 2013-2018
7.2.2.5 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share by Countries 2013-2018
7.3 World Price (USD/Unit) by Regions and Countries 2013-2018
7.3.1 World Price (USD/Unit) by Regions 2013-2018
7.3.2 Regional Price (USD/Unit) by Countries 2013-2018
7.3.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Countries 2013-2018
7.3.2.2 North America Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Countries 2013-2018
7.3.2.3 Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Countries 2013-2018
7.3.2.4 South America Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Countries 2013-2018
7.3.2.5 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Countries 2013-2018
7.4 World Gross Margin by Regions and Countries 2013-2018
7.4.1 World Gross Margin by Regions 2013-2018
7.4.2 Regional Gross Margin and Share by Countries 2013-2018
7.4.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Gross Margin and Share by Countries 2013-2018
7.4.2.2 North America Opioid Induced Constipation (OIC) Drugs Gross Margin and Share by Countries 2013-2018
7.4.2.3 Europe Opioid Induced Constipation (OIC) Drugs Gross Margin and Share by Countries 2013-2018
7.4.2.4 South America Opioid Induced Constipation (OIC) Drugs Gross Margin and Share by Countries 2013-2018
7.4.2.5 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Gross Margin and Share by Countries 2013-2018
8 Development Trend for Regions and Countries (Sales Point)
8.1 World Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3 North America Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5 South America Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Hospital Pharmacies Industry
11.2 Retail Pharmacies Industry
11.3 Online Pharmacies Industry
12 Market Forecast 2019-2024
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
12.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
12.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Growth Rate 2019-2024
12.1.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.4 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.5 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.6 South America Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.7 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2 Sales (K Units), Revenue (M USD) by Types 2019-2024
12.2.1 Overall Market Performance
12.2.2 Lubiprostone Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.3 Methyl Naltrexone Bromide Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.4 Naldemedine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.2.5 Alvimopan Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3 Sales by Application 2019-2024
12.3.1 Overall Market Performance
12.3.2 Hospital Pharmacies Sales and and Growth Rate 2019-2024
12.3.3 Retail Pharmacies Sales and and Growth Rate 2019-2024
12.3.4 Online Pharmacies Sales and and Growth Rate 2019-2024
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) Trend 2019-2024
12.4.2 Global Opioid Induced Constipation (OIC) Drugs Gross Profit Trend 2019-2024
13 Conclusion
List of Tables and Figures
Figure Product Picture of Opioid Induced Constipation (OIC) Drugs
Table Product Specifications of Opioid Induced Constipation (OIC) Drugs
Table Manufacturers List in the Report
Table Manufacturers Market Share 2013-2018
Table Regions Overview in the Report
Table Product Type and Standard
Table Type Overview
Table Product Application and Standard
Table Application Overview in the Report
Figure Industry Chain Structure of Opioid Induced Constipation (OIC) Drugs
Table Industry News List of Opioid Induced Constipation (OIC) Drugs
Figure New Project SWOT Analysis of Opioid Induced Constipation (OIC) Drugs
Table World 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Type
Figure World Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2013
Figure World Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2018
Table World 2013-2018 Opioid Induced Constipation (OIC) DrugsRevenue (M USD) by Type
Figure World Opioid Induced Constipation (OIC) DrugsRevenue Market Share (%) by Type in 2013
Figure World Opioid Induced Constipation (OIC) DrugsRevenue Market Share (%) by Type in 2018
Table World Lubiprostone Sales (K Units) and Growth Rate
Figure World Lubiprostone Sales (K Units) and Growth Rate
Table World Lubiprostone Revenue (M USD) and Growth Rate
Figure World Lubiprostone Revenue (M USD) and Growth Rate
Table World Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Figure World Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Table World Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Figure World Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Table World Naldemedine Sales (K Units) and Growth Rate
Figure World Naldemedine Sales (K Units) and Growth Rate
Table World Naldemedine Revenue (M USD) and Growth Rate
Figure World Naldemedine Revenue (M USD) and Growth Rate
Table World Alvimopan Sales (K Units) and Growth Rate
Figure World Alvimopan Sales (K Units) and Growth Rate
Table World Alvimopan Revenue (M USD) and Growth Rate
Figure World Alvimopan Revenue (M USD) and Growth Rate
Table North America 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Type
Figure North America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2013
Figure North America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2018
Table North America 2013-2018 Opioid Induced Constipation (OIC) DrugsRevenue (M USD) by Type
Figure North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Type in 2013
Figure North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Type in 2018
Table North America Lubiprostone Sales (K Units) and Growth Rate
Figure North America Lubiprostone Sales (K Units) and Growth Rate
Table North America Lubiprostone Revenue (M USD) and Growth Rate
Figure North America Lubiprostone Revenue (M USD) and Growth Rate
Table North America Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Figure North America Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Table North America Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Figure North America Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Table North America Naldemedine Sales (K Units) and Growth Rate
Figure North America Naldemedine Sales (K Units) and Growth Rate
Table North America Naldemedine Revenue (M USD) and Growth Rate
Figure North America Naldemedine Revenue (M USD) and Growth Rate
Table North America Alvimopan Sales (K Units) and Growth Rate
Figure North America Alvimopan Sales (K Units) and Growth Rate
Table North America Alvimopan Revenue (M USD) and Growth Rate
Figure North America Alvimopan Revenue (M USD) and Growth Rate
Table Europe 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Type
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2013
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2018
Table Europe 2013-2018 Opioid Induced Constipation (OIC) DrugsRevenue (M USD) by Type
Figure Europe Opioid Induced Constipation (OIC) DrugsRevenue Market Share (%) by Type in 2013
Figure Europe Opioid Induced Constipation (OIC) DrugsRevenue Market Share (%) by Type in 2018
Table Europe Lubiprostone Sales (K Units) and Growth Rate
Figure Europe Lubiprostone Sales (K Units) and Growth Rate
Table Europe Lubiprostone Revenue (M USD) and Growth Rate
Figure Europe Lubiprostone Revenue (M USD) and Growth Rate
Table Europe Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Figure Europe Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Table Europe Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Figure Europe Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Table Europe Naldemedine Sales (K Units) and Growth Rate
Figure Europe Naldemedine Sales (K Units) and Growth Rate
Table Europe Naldemedine Revenue (M USD) and Growth Rate
Figure Europe Naldemedine Revenue (M USD) and Growth Rate
Table Europe Alvimopan Sales (K Units) and Growth Rate
Figure Europe Alvimopan Sales (K Units) and Growth Rate
Table Europe Alvimopan Revenue (M USD) and Growth Rate
Figure Europe Alvimopan Revenue (M USD) and Growth Rate
Table Asia-Pacific 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Type
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2013
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2018
Table Asia-Pacific 2013-2018 Opioid Induced Constipation (OIC) DrugsRevenue (M USD) by Type
Figure Asia-Pacific Opioid Induced Constipation (OIC) DrugsRevenue Market Share (%) by Type in 2013
Figure Asia-Pacific Opioid Induced Constipation (OIC) DrugsRevenue Market Share (%) by Type in 2018
Table Asia-Pacific Lubiprostone Sales (K Units) and Growth Rate
Figure Asia-Pacific Lubiprostone Sales (K Units) and Growth Rate
Table Asia-Pacific Lubiprostone Revenue (M USD) and Growth Rate
Figure Asia-Pacific Lubiprostone Revenue (M USD) and Growth Rate
Table Asia-Pacific Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Figure Asia-Pacific Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Table Asia-Pacific Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Figure Asia-Pacific Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Table Asia-Pacific Naldemedine Sales (K Units) and Growth Rate
Figure Asia-Pacific Naldemedine Sales (K Units) and Growth Rate
Table Asia-Pacific Naldemedine Revenue (M USD) and Growth Rate
Figure Asia-Pacific Naldemedine Revenue (M USD) and Growth Rate
Table Asia-Pacific Alvimopan Sales (K Units) and Growth Rate
Figure Asia-Pacific Alvimopan Sales (K Units) and Growth Rate
Table Asia-Pacific Alvimopan Revenue (M USD) and Growth Rate
Figure Asia-Pacific Alvimopan Revenue (M USD) and Growth Rate
Table South America 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Type
Figure South America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2013
Figure South America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2018
Table South America 2013-2018 Opioid Induced Constipation (OIC) DrugsRevenue (M USD) by Type
Figure South America Opioid Induced Constipation (OIC) DrugsRevenue Market Share (%) by Type in 2013
Figure South America Opioid Induced Constipation (OIC) DrugsRevenue Market Share (%) by Type in 2018
Table South America Lubiprostone Sales (K Units) and Growth Rate
Figure South America Lubiprostone Sales (K Units) and Growth Rate
Table South America Lubiprostone Revenue (M USD) and Growth Rate
Figure South America Lubiprostone Revenue (M USD) and Growth Rate
Table South America Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Figure South America Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Table South America Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Figure South America Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Table South America Naldemedine Sales (K Units) and Growth Rate
Figure South America Naldemedine Sales (K Units) and Growth Rate
Table South America Naldemedine Revenue (M USD) and Growth Rate
Figure South America Naldemedine Revenue (M USD) and Growth Rate
Table South America Alvimopan Sales (K Units) and Growth Rate
Figure South America Alvimopan Sales (K Units) and Growth Rate
Table South America Alvimopan Revenue (M USD) and Growth Rate
Figure South America Alvimopan Revenue (M USD) and Growth Rate
Table Middle East and Africa 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Type
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2013
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Type in 2018
Table Middle East and Africa 2013-2018 Opioid Induced Constipation (OIC) DrugsRevenue (M USD) by Type
Figure Middle East and Africa Opioid Induced Constipation (OIC) DrugsRevenue Market Share (%) by Type in 2013
Figure Middle East and Africa Opioid Induced Constipation (OIC) DrugsRevenue Market Share (%) by Type in 2018
Table Middle East and Africa Lubiprostone Sales (K Units) and Growth Rate
Figure Middle East and Africa Lubiprostone Sales (K Units) and Growth Rate
Table Middle East and Africa Lubiprostone Revenue (M USD) and Growth Rate
Figure Middle East and Africa Lubiprostone Revenue (M USD) and Growth Rate
Table Middle East and Africa Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Figure Middle East and Africa Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Table Middle East and Africa Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Figure Middle East and Africa Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Table Middle East and Africa Naldemedine Sales (K Units) and Growth Rate
Figure Middle East and Africa Naldemedine Sales (K Units) and Growth Rate
Table Middle East and Africa Naldemedine Revenue (M USD) and Growth Rate
Figure Middle East and Africa Naldemedine Revenue (M USD) and Growth Rate
Table Middle East and Africa Alvimopan Sales (K Units) and Growth Rate
Figure Middle East and Africa Alvimopan Sales (K Units) and Growth Rate
Table Middle East and Africa Alvimopan Revenue (M USD) and Growth Rate
Figure Middle East and Africa Alvimopan Revenue (M USD) and Growth Rate
Table World 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Application
Figure World Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2013
Figure World Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2018
Table World Hospital Pharmacies Sales (K Units) and Growth Rate
Figure World Hospital Pharmacies Sales (K Units) and Growth Rate
Table World Retail Pharmacies Sales (K Units) and Growth Rate
Figure World Retail Pharmacies Sales (K Units) and Growth Rate
Table World Online Pharmacies Sales (K Units) and Growth Rate
Figure World Online Pharmacies Sales (K Units) and Growth Rate
Table North America 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Application
Figure North America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2013
Figure North America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2018
Table North America Hospital Pharmacies Sales (K Units) and Growth Rate
Figure North America Hospital Pharmacies Sales (K Units) and Growth Rate
Table North America Retail Pharmacies Sales (K Units) and Growth Rate
Figure North America Retail Pharmacies Sales (K Units) and Growth Rate
Table North America Online Pharmacies Sales (K Units) and Growth Rate
Figure North America Online Pharmacies Sales (K Units) and Growth Rate
Table Europe 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Application
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2013
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2018
Table Europe Hospital Pharmacies Sales (K Units) and Growth Rate
Figure Europe Hospital Pharmacies Sales (K Units) and Growth Rate
Table Europe Retail Pharmacies Sales (K Units) and Growth Rate
Figure Europe Retail Pharmacies Sales (K Units) and Growth Rate
Table Europe Online Pharmacies Sales (K Units) and Growth Rate
Figure Europe Online Pharmacies Sales (K Units) and Growth Rate
Table Asia-Pacific 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Application
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2013
Figure Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2018
Table Asia-Pacific Hospital Pharmacies Sales (K Units) and Growth Rate
Figure Asia-Pacific Hospital Pharmacies Sales (K Units) and Growth Rate
Table Asia-Pacific Retail Pharmacies Sales (K Units) and Growth Rate
Figure Asia-Pacific Retail Pharmacies Sales (K Units) and Growth Rate
Table Asia-Pacific Online Pharmacies Sales (K Units) and Growth Rate
Figure Asia-Pacific Online Pharmacies Sales (K Units) and Growth Rate
Table South America 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Application
Figure South America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2013
Figure South America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2018
Table South America Hospital Pharmacies Sales (K Units) and Growth Rate
Figure South America Hospital Pharmacies Sales (K Units) and Growth Rate
Table South America Retail Pharmacies Sales (K Units) and Growth Rate
Figure South America Retail Pharmacies Sales (K Units) and Growth Rate
Table South America Online Pharmacies Sales (K Units) and Growth Rate
Figure South America Online Pharmacies Sales (K Units) and Growth Rate
Table Middle East and Africa 2013-2018 Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Application
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2013
Figure Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2018
Table Middle East and Africa Hospital Pharmacies Sales (K Units) and Growth Rate
Figure Middle East and Africa Hospital Pharmacies Sales (K Units) and Growth Rate
Table Middle East and Africa Retail Pharmacies Sales (K Units) and Growth Rate
Figure Middle East and Africa Retail Pharmacies Sales (K Units) and Growth Rate
Table Middle East and Africa Online Pharmacies Sales (K Units) and Growth Rate
Figure Middle East and Africa Online Pharmacies Sales (K Units) and Growth Rate
Table Ironwood Pharmaceuticals Inc Profiles
Table Ironwood Pharmaceuticals Inc Product Information
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Daiichi Sankyo Co Ltd Profiles
Table Daiichi Sankyo Co Ltd Product Information
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Pfizer Profiles
Table Pfizer Product Information
Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Pfizer Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Progenics Pharmaceuticals Inc Profiles
Table Progenics Pharmaceuticals Inc Product Information
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Shionogi & Co., Ltd Profiles
Table Shionogi & Co., Ltd Product Information
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Allergan Plc Profiles
Table Allergan Plc Product Information
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Nektar Therapeutics Profiles
Table Nektar Therapeutics Product Information
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Purdue Pharma Profiles
Table Purdue Pharma Product Information
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table S.L.A. Pharma AG Profiles
Table S.L.A. Pharma AG Product Information
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Mundipharma International Limited Profiles
Table Mundipharma International Limited Product Information
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table World Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2013-2018
Table World Opioid Induced Constipation (OIC) Drugs Sales Share of Manufacturers 2013-2018
Figure World Opioid Induced Constipation (OIC) Drugs Sales Share in 2013
Figure World Opioid Induced Constipation (OIC) Drugs Sales Share in 2018
Table World Revenue (M USD) of Manufacturers 2013-2018
Table World Revenue Share of Manufacturers 2013-2018
Figure World Revenue Share in 2013
Figure World Revenue Share in 2018
Table World Price (USD/Unit) of Manufacturers 2013-2018
Cross-segment Market Size and Analysis for
Mentioned Segments
